TCWM
KZIA

Total Clarity Wealth Management’s Kazia Therapeutics KZIA Stock Holding History

Total Clarity Wealth Management’s Portfolio KZIA Stock Details KZIA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-95
Closed -$54K – 1025
2021
Q3 		$54K Buy
+95
New +$46.7K 0.03% 390
2021
Q2 		– Sell
-36
Closed -$22K – 484
2021
Q1 		$22K Buy
+36
New +$18.8K 0.01% 450

Other funds holding KZIA

Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
SG Americas Securities
SG Americas Securities New York $92.9B AUM 36.98% 1-Year Est. Return
Truist Financial
Truist Financial Charlotte, North Carolina $83.7B AUM 27.22% 1-Year Est. Return
Envestnet Asset Management
Envestnet Asset Management Chicago, Illinois $424B AUM 22.96% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Simplex Trading
Simplex Trading Chicago, Illinois $149B AUM 62.07% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
SPIA
Steward Partners Investment Advisory New York $19.6B AUM 22.89% 1-Year Est. Return

Total Clarity Wealth Management's KZIA Position: Q4 2021 in Review

Total Clarity Wealth Management sold out of Kazia Therapeutics (KZIA) in Q4 2021, closing a stake of 95 shares — an estimated $54K sold.

Total Clarity Wealth Management first reported a position in KZIA in Q1 2021 and held it in 2 quarters. The position peaked at $54K in Q3 2021. 10 funds tracked by Wall St. Rank hold KZIA as of Q4 2021.

  • Total Clarity Wealth Management reported no remaining Kazia Therapeutics position as of Q4 2021 after selling out during the quarter.
  • Total Clarity Wealth Management sold 95 Kazia Therapeutics shares in Q4 2021, an estimated $54K.
  • Total Clarity Wealth Management first reported a position in Kazia Therapeutics in Q1 2021 and held it in 2 quarters.
  • Total Clarity Wealth Management's Kazia Therapeutics position peaked at $54K in Q3 2021.
  • 10 funds tracked by Wall St. Rank held Kazia Therapeutics as of Q4 2021.

Based on Total Clarity Wealth Management's 13F filing for Q4 2021, filed 3 Feb 2022.